Mr. White has over a decade of experience in the biotech and specialty pharmaceutical industries. Mr. White provides strategic guidance to clients in market access, coverage and reimbursement, launch planning, patient program design, pricing and contracting. Mr. White holds a BS Business from Post University and is a Certified Professional Coder with the American Academy of Professional Coders.

Jayson Slotnik is a well-respected thought leader in CMS and FDA policy, having worked inside the Beltway for his entire career. Jayson served as Director for Medicare Reimbursement and Economics at the Biotechnology International Organization (BIO), representing the industry before Congress and CMS regarding reimbursement, coverage and payment issues. He is currently Partner at Health Policy Strategies, an independent firm specializing in coverage, coding, and reimbursement strategies.

Michael McCaughan is a founding member of Prevision Policy LLC and editor of The RPM Report, a leading publication focusing on the intersection between biopharmaceutical regulation, policy and business. Previously, McCaughan was Editor-in-Chief of Elsevier Business Intelligence’s Biopharma Group, the leading publisher of news and information services for the pharmaceutical industry, including The Pink Sheet, IN VIVO, The RPM Report, PharmAsia News, and The IN VIVO Blog.

Steve Bloom has more than 25 years of commercial experience in the pharmaceutical, biotechnology and outcomes/reimbursement industries. He is currently responsible for a full array of business development activities (identification & evaluation of opportunities, structuring and negotiating transactions, out-licensing and alliance management). In addition, Mr Bloom is responsible for the commercial assessment and planning for the late stage clinical pipeline of the company.

In April 2006, Kay Barry joined Shire as the National Account Executive responsible for educating managed care organizations, several managed Medicaid health plans and specialty pharmacies. In 2007, she was promoted to Senior Manager, Government Affairs responsible for monitoring public payer policy nationally as well as reimbursement and access for Shire patients with Medicaid and Medicare. In 2010, Ms. Barry was promoted to Director, Government Accounts, for the launch of Vpriv.

Jeff Fetterman is President of ParagonRx, a company specializing in REMS (Risk Evaluation and Mitigation Strategies) and benefit-risk management for pharmaceutical, biotech and medical device industries. As co-author of two pharmaceutical risk management books and consultant for numerous risk management programs, he is helping to pioneer this field in our industry.

Jeff Trotter is Executive Vice President of the Phase IV Development Group at PharmaNet, part of inVentiv Health’s clinical division. As an entrepreneur, researcher, consultant, and industry leader for the past 25 years, he has been a pioneer in the evolving health economics and outcomes research community. Mr. Trotter joined PharmaNet in 2009 and provides leadership for the Company’s Phase IV operations and global expansion.

Lujing Wang is a physician and health economist who leads Campbell Alliance’s Pricing and Market Access Practice, which provides services related to pharmaceutical pricing, market access, and reimbursement. Dr. Wang earned his MPH from Harvard University. He also earned an MD from Peking Union Medical College and his undergraduate degree from Peking University.

Katya Svoboda brings over fifteen years of broad experience in the healthcare industry to Campbell Alliance’s Pricing and Market Access practice. She has led numerous successful consulting engagements involving diverse business challenges, therapeutic areas, and products. Katya has an MBA and MPH from Yale University and a BS in economics and psychology from Boston University.

Mike Banigan is the Founder and President of Chronic Disease Fund®, the nation’s largest and most effective provider of financial and medication assistance for those with chronic illness and cancer. Banigan’s background in the pharmaceutical and healthcare-services arena, coupled with his years in finance and reinsurance, helped him revolutionize the patient assistance industry, paving the way for all others in this arena. An entrepreneur since his early thirties, Banigan has founded several other novel companies in various industries.

Marc Palmer currently serves as CEO of inVentiv Medical Management, a cost containment and disease management firm. Prior to joining inVentiv Medical Management, he was CEO of ConnectYourCare, an Express Scripts company focused on consumer directed healthcare administrator. Marc has over 20 years of leadership experience in the insurance sector, having worked at Capitol American Life Insurance Company prior to joining Express Scripts. Marc has a BA in Journalism and BA in Physical Education from the University of Southern California, and resides in the greater St. Louis area.

Mr. Calabrese is Vice President, Clinical Operations for MedMetrics Health Partners, a wholly-owned subsidiary of SXC Health Solutions, providing full-service pharmacy benefit management (PBM) services to both public and private sector third-party payors. Mr. Calabrese maintains oversight and strategic accountability for MedMetrics’ full portfolio of clinical programs and services, as well as pharmacy analytics, pharmaceutical contracting, specialty pharmacy management and client support services. He maintains an additional role as Clinical Editor of the peer-reviewed pharmacy journal Formulary, a clinical publication received by more than 50,000 pharmacists and physicians nationwide.

Dr. Marttila serves as the Director of the Pharmaceutical Contracting and Formulary Management area (Institutional and Managed Care Contracts) at Mayo Clinic where he has been in various pharmaceutical managerial positions for 24 years. Previously, he spent over 15 years working in academia, long term care and managed care consulting, in addition to pharmacy ownership in Clinic and Retail Pharmacy.

Elise Berliner, Ph.D., is the Director of the Technology Assessment Program at the Agency for Healthcare Research and Quality (AHRQ). The Technology Assessment program provides technology assessments to the Centers for Medicare & Medicaid Services (CMS) to inform Medicare coverage decisions and other policy issues. Prior to joining AHRQ, Dr. Berliner worked as a consultant to pharmaceutical and medical device companies on cost-effectiveness and outcomes research, technology assessment and reimbursement planning. She was a Congressional Fellow at the Office of Technology Assessment. Dr. Berliner received her Ph.D. in biophysics from Brandeis University.